Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mertens

Showing results (441-450 of 479) with videos related to

Pageof 48
Sort By:
Kidney International|November 22, 2024
Corrigendum to "CD248 induces a maladaptive unfolded protein response in diabetic kidney disease." Kidney International 2023;103:304-319Shruthi Krishnan, Jayakumar Manoharan, Hongjie Wang, et al.
Kidney International|October 29, 2022
CD248 induces a maladaptive unfolded protein response in diabetic kidney diseaseShruthi Krishnan, Jayakumar Manoharan, Hongjie Wang, et al.
Molecular Pharmacology|June 28, 2007
The phosphoinositide-dependent kinase-1 inhibitor 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) prevents Y-box binding protein-1 from inducing epidermal growth factor receptorK To, Y Zhao, H Jiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2013
YB-1 is an early and central mediator of bacterial and sterile inflammation in vivoLydia Hanssen, Christina Alidousty, Sonja Djudjaj, et al.
The Journal of Pathology|July 19, 2012
Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injurySonja Djudjaj, Christos Chatziantoniou, Ute Raffetseder, et al.
Renal Failure|October 25, 2018
The contribution of genetic variants of SLC2A1 gene in T2DM and T2DM-nephropathy: association study and meta-analysisI Stefanidis, M Tziastoudi, E E Tsironi, et al.
International Urology and Nephrology|February 25, 2022
Midkine release during hemodialysis is predictive of hypervolemia and associates with excess (cardiovascular) mortality in patients with end-stage renal disease: a prospective studySabine Brandt, Anja Fischer, Carla Kreutze, et al.
BMC Nephrology|December 7, 2005
The IgA nephropathy Biobank. An important starting point for the genetic dissection of a complex traitFrancesco P Schena, Giuseppina Cerullo, Diletta D Torres, et al.
Journal of the American Society of Nephrology : JASN|July 12, 2017
Farnesoid X Receptor Agonism Protects against Diabetic Tubulopathy: Potential Add-On Therapy for Diabetic NephropathyAndi Marquardt, Moh'd Mohanad Al-Dabet, Sanchita Ghosh, et al.
Journal of the American Society of Nephrology : JASN|October 19, 2017
Effects of Two Immunosuppressive Treatment Protocols for IgA NephropathyThomas Rauen, Christina Fitzner, Frank Eitner, et al.
Pageof 48

Showing results (441-450 of 479) with videos related to

Sort By:
Pageof 48
Kidney International|November 22, 2024
Corrigendum to "CD248 induces a maladaptive unfolded protein response in diabetic kidney disease." Kidney International 2023;103:304-319Shruthi Krishnan, Jayakumar Manoharan, Hongjie Wang, et al.
Kidney International|October 29, 2022
CD248 induces a maladaptive unfolded protein response in diabetic kidney diseaseShruthi Krishnan, Jayakumar Manoharan, Hongjie Wang, et al.
Molecular Pharmacology|June 28, 2007
The phosphoinositide-dependent kinase-1 inhibitor 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) prevents Y-box binding protein-1 from inducing epidermal growth factor receptorK To, Y Zhao, H Jiang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 23, 2013
YB-1 is an early and central mediator of bacterial and sterile inflammation in vivoLydia Hanssen, Christina Alidousty, Sonja Djudjaj, et al.
The Journal of Pathology|July 19, 2012
Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injurySonja Djudjaj, Christos Chatziantoniou, Ute Raffetseder, et al.
Renal Failure|October 25, 2018
The contribution of genetic variants of SLC2A1 gene in T2DM and T2DM-nephropathy: association study and meta-analysisI Stefanidis, M Tziastoudi, E E Tsironi, et al.
International Urology and Nephrology|February 25, 2022
Midkine release during hemodialysis is predictive of hypervolemia and associates with excess (cardiovascular) mortality in patients with end-stage renal disease: a prospective studySabine Brandt, Anja Fischer, Carla Kreutze, et al.
BMC Nephrology|December 7, 2005
The IgA nephropathy Biobank. An important starting point for the genetic dissection of a complex traitFrancesco P Schena, Giuseppina Cerullo, Diletta D Torres, et al.
Journal of the American Society of Nephrology : JASN|July 12, 2017
Farnesoid X Receptor Agonism Protects against Diabetic Tubulopathy: Potential Add-On Therapy for Diabetic NephropathyAndi Marquardt, Moh'd Mohanad Al-Dabet, Sanchita Ghosh, et al.
Journal of the American Society of Nephrology : JASN|October 19, 2017
Effects of Two Immunosuppressive Treatment Protocols for IgA NephropathyThomas Rauen, Christina Fitzner, Frank Eitner, et al.
Pageof 48